Rincon Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Rincon Pharmaceuticals General Information

Description

Developer of recombinant protein therapeutics. The company focuses on increasing the availability of recombinant protein therapeutics, such as monoclonal antibodies, by using eukaryotic algae as a rapid and efficient production system.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 318
  • San Diego, CA 92109
  • United States
+1 (858)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 318
  • San Diego, CA 92109
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rincon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jul-2008 Completed Generating Revenue
2. Later Stage VC (Series A) 17-Oct-2007 Completed Startup
1. Early Stage VC (Series A) 15-Nov-2005 $4.7M $4.7M Completed Startup
To view Rincon Pharmaceuticals’s complete valuation and funding history, request access »

Rincon Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Rincon Pharmaceuticals’s complete cap table history, request access »

Rincon Pharmaceuticals Patents

Rincon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110151515-A1 Production of fc-fusion polypeptides in eukaryotic algae Inactive 13-Nov-2007

Rincon Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Paperboy Ventures Merchant Banking Firm Minority
To view Rincon Pharmaceuticals’s complete investors history, request access »

Rincon Pharmaceuticals FAQs

  • When was Rincon Pharmaceuticals founded?

    Rincon Pharmaceuticals was founded in 2002.

  • Where is Rincon Pharmaceuticals headquartered?

    Rincon Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Rincon Pharmaceuticals in?

    Rincon Pharmaceuticals’s primary industry is Discovery Tools (Healthcare).

  • Is Rincon Pharmaceuticals a private or public company?

    Rincon Pharmaceuticals is a Private company.

  • What is Rincon Pharmaceuticals’s current revenue?

    The current revenue for Rincon Pharmaceuticals is .

  • How much funding has Rincon Pharmaceuticals raised over time?

    Rincon Pharmaceuticals has raised $10M.

  • Who are Rincon Pharmaceuticals’s investors?

    Paperboy Ventures has invested in Rincon Pharmaceuticals.

  • When was Rincon Pharmaceuticals acquired?

    Rincon Pharmaceuticals was acquired on 01-Jul-2008.

  • Who acquired Rincon Pharmaceuticals?

    Rincon Pharmaceuticals was acquired by Sapphire Energy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process